文献速递区域麻醉与超声疼痛医学

静脉与神经周围地塞米松延长肌间沟臂丛阻滞镇痛的比较:系统评价与Meta分析

Intravenous versus perineural dexamethasone to prolong analgesia after interscalene brachial plexus block: a systematic review with meta-analysis and trial sequential analysis.
PubMed 文献 · Br J Anaesth · 2024-05-23

该系统评价纳入11项试验共1145例患者,比较神经周围与静脉注射地塞米松作为局麻药佐剂用于肌间沟臂丛阻滞的镇痛持续时间。神经周围组镇痛持续时间平均延长122分钟(95%CI 62-183),但证据质量低,且差异临床相关性有限,作者推荐静脉给药。

要点

  • 神经周围地塞米松较静脉注射平均延长镇痛时间约2小时,但证据质量低。
  • 该差异临床相关性有限,且神经周围给药属超说明书使用并有药物结晶风险。
  • 作者推荐静脉注射地塞米松作为肌间沟臂丛阻滞的佐剂。

核心结论

  • 低质量证据表明,神经周围地塞米松较静脉注射平均延长镇痛持续时间约2小时,但鉴于临床相关性有限、超说明书使用及结晶风险,推荐静脉给药。

研究设计与样本

  • 系统评价与Meta分析及试验序贯分析,共纳入11项试验、1145例患者,检索多个电子数据库,方案注册于PROSPERO(CRD42023466147)。

主要发现

  • 主要结局镇痛持续时间在神经周围地塞米松组更长,平均差异122分钟(95%CI 62-183),I2=73%,P<0.0001,试验序贯分析达到确切证据。
  • 证据质量降级为低,主要因中等异质性和严重发表偏倚。
  • 除感觉和运动阻滞起效时间及12小时静息疼痛评分外,其他次要结局无显著差异,但差异幅度无临床相关性。

关键数值与推荐

  • 镇痛持续时间平均差异122分钟(95%CI 62-183),I2=73%,P<0.0001,证据质量低。

临床怎么用

  • 对于肌间沟臂丛阻滞,推荐静脉注射地塞米松而非神经周围给药,以避免超说明书使用和药物结晶风险。

局限性

  • 证据质量低,主要因中等异质性和严重发表偏倚;神经周围给药为超说明书使用且有结晶风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The efficacy of perineural vs intravenous dexamethasone as a local anaesthetic adjunct to increase duration of analgesia could be particular to specific peripheral nerve blocks because of differences in systemic absorption depending on the injection site. Given this uncertainty, we performed a systematic review with meta-analysis and trial sequential analysis comparing dexamethasone administered perineurally or intravenously combined with local anaesthetic for interscalene brachial plexus block. METHODS: Following a search of various electronic databases, we included 11 trials (1145 patients). The primary outcome was the duration of analgesia defined as the time between peripheral nerve block or onset of sensory blockade and the time to first analgesic request or initial report of pain. RESULTS: The primary outcome, duration of analgesia, was greater in the perineural dexamethasone group, with a mean difference (95% confidence interval) of 122 (62-183) min, I2=73%, P<0.0001. Trial sequential analysis indicated that firm evidence had been reached. The quality of evidence was downgraded to low, mainly because of moderate inconsistency and serious publication bias. No significant differences were present for any of the secondary outcomes, except for onset time of sensory and motor blockade and resting pain score at 12 h, but the magnitude of differences was not clinically relevant. CONCLUSIONS: There is low-quality evidence that perineural administration of dexamethasone as a local anaesthetic adjunct increases duration of analgesia by an average of 2 h compared with intravenous injection for interscalene brachial plexus block. Given the limited clinical relevance of this difference, the off-label use of perineural administration, and the risk of drug crystallisation, we recommend intravenous dexamethasone administration. SYSTEMATIC REVIEW PROTOCOL: PROSPERO (CRD42023466147).

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Albrecht E, Renard Y, Desai N, et al. Intravenous versus perineural dexamethasone to prolong analgesia after interscalene brachial plexus block: a systematic review with meta-analysis and trial sequential analysis. Br J Anaesth. 2024. PMID: 38782616. doi:10.1016/j.bja.2024.03.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。